Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 5/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL1502817 | 0.98 | HTT (0.79) | HTTKMT2AMEN1MAPTTP53 | |
| Hydrochloric Acid SCHEMBL244803 | 0.98 | HTT (0.79) | HTTKMT2AMEN1MAPTTP53 | |
| Bromide SCHEMBL193632 | 0.98 | HTT (0.79) | HTTKMT2AMEN1MAPTTP53 | |
| Iodide SCHEMBL1502769 | 0.98 | HTT (0.79) | HTTKMT2AMEN1MAPTTP53 | |
| Water SCHEMBL2150255 | 0.98 | HTT (0.79) | HTTKMT2AMEN1MAPTTP53 | |
| Hydrochloric Acid SCHEMBL26106948 | 0.95 | HTT (0.76) | HTTKMT2AMEN1MAPTTP53 | |
| SCHEMBL30330430 | 0.93 | HTT (0.73) | HTTKMT2AMEN1MAPTTP53 | |
| SCHEMBL2872450 | 0.93 | HTT (0.95) | HTTKMT2AMEN1MAPTTP53 | |
| SCHEMBL29048071 | 0.91 | HTT (0.70) | HTTKMT2AMEN1MAPTSMN1; SMN2 | |
| SCHEMBL193446 | 0.91 | HTT (0.70) | HTTKMT2AMEN1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1865 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085568-A | Ion gel electrolyte composition capable of being subjected to room-temperature in-situ spontaneous polymerization, electrolyte and application | — | 2026-05-26 | — | — | CN | claimed |
| US-20260130113-A1 | PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS AND METHODS OF MAKING PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS | E INK CORP (US) | 2026-05-07 | — | — | US | claimed |
| EP-3251133-B1 | WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR | FASTCAP ULTRACAPACITORS LLC (US) | 2025-12-24 | — | — | EP | claimed |
| WO-2025227074-A1 | USE OF ORGANIC CATIONS FOR SELECTIVE ELECTROCHEMICAL CO2 CONVERSION TO METHANOL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4614540-A2 | CHIP FORM ULTRACAPACITOR | FastCAP Ultracapacitors LLC (US) | 2025-09-10 | — | — | EP | claimed |
| EP-4612118-A1 | METHOD OF CONVERTING POLY(ETHYLENE TEREPHTHALATE) TO TEREPHTHALIC ACID | SHPP Global Technologies B.V. (NL) | 2025-09-10 | — | — | EP | claimed |
| US-12365647-B2 | Method for preparing acrylonitrile dimer | LG CHEM, LTD. (KR) | 2025-07-22 | — | — | US | claimed |
| US-20250196021-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-19 | — | — | US | claimed |
| WO-2025128828-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250179894-A1 | POWER SYSTEM FOR HIGH TEMPERATURE APPLICATIONS WITH RECHARGEABLE ENERGY STORAGE | FASTCAP ULTRACAPACITORS LLC | 2025-06-05 | — | — | US | claimed |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-10-20 | — | — | US | claimed |
| WO-2005094785-A2 | COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER | CHIASMA, LTD. (IL) | 2005-10-13 | — | — | WO | claimed |
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CHIASMA, INC. | 2005-06-23 | — | — | US | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| US-20050058702-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-03-17 | — | — | US | claimed |
| US-6852229-B2 | Filtration; for prevention of destruction of catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2005-02-08 | — | — | US | claimed |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2004-07-29 | — | — | US | claimed |
| US-20040074842-A1 | Filtration; for prevention of destruction of catalyst | EXXONMOBIL RESEARCH ENGINEERING CO. | 2004-04-22 | — | — | US | claimed |
| EP-1362572-A1 | Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
| US-4287335-A | WHEREIN SAID COMPOUND IS A STYRYLPYRIDINIUM SALT OR A STYRYLQUINOLINIUM SALT USEFUL IN PRODUCING A PHOTOSENSITIVE RESIN | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1981-09-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CFTR, SLC47A1, SLC47A2 | HTT 677/4885KMT2A 4606/4885MEN1 1463/4885 |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | MMP8, PGF, AQP1 | HTT 684/4885KMT2A 4879/4885MEN1 2141/4885 |
| US-20260130113-A1 | PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS AND METHODS OF MAKING PIEZOELECTRIC FILMS INCLUDING IONIC LIQUIDS | PIEZO1, MEF2D, CDH1 | HTT 4835/4885KMT2A 1595/4885MEN1 670/4885 |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | SLC7A1, SLC1A5, SLC3A2 | HTT 366/4885KMT2A 4471/4885MEN1 2096/4885 |
| US-12365647-B2 | Method for preparing acrylonitrile dimer | ADH1C, ADH1A, PUF60 | HTT 4222/4885KMT2A 4707/4885MEN1 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.